You are here » Home » Companies » Company Overview » Syncom Formulations (India) Ltd

Syncom Formulations (India) Ltd.

BSE: 524470 Sector: Health care
NSE: N.A. ISIN Code: INE312C01025
BSE LIVE 15:49 | 09 Dec 2.22 0.01
(0.45%)
OPEN

2.20

HIGH

2.30

LOW

2.17

NSE LIVE 05:30 | 01 Jan Stock Is Not Traded.
OPEN 2.20
PREVIOUS CLOSE 2.21
VOLUME 1841043
52-Week high 5.40
52-Week low 1.91
P/E 17.08
Mkt Cap.(Rs cr) 173.32
Buy Price 0.00
Buy Qty 0.00
Sell Price 2.22
Sell Qty 1869.00
OPEN 2.20
CLOSE 2.21
VOLUME 1841043
52-Week high 5.40
52-Week low 1.91
P/E 17.08
Mkt Cap.(Rs cr) 173.32
Buy Price 0.00
Buy Qty 0.00
Sell Price 2.22
Sell Qty 1869.00

About Syncom Formulations (India) Ltd.

Syncom Formulations (India) Ltd

Incorporated as a private limited company in 1988, Syncom Formulations (India) was converted into a public limited company in Jun.'92. The company set up a manufacturing facility at Palghar, Thane to produce pharmaceutical formulations. Commercial production commenced in Apr.'89. Promoters are Kedarmal Bankda, Vijay Kumar Bankda and Ajay Kumar Bankda. In addition to pharmaceutical formulations ...> More

Syncom Formulations (India) Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   173
EPS - TTM () [*S] 0.13
P/E Ratio (X) [*S] 17.08
Face Value ()   1
Latest Dividend (%)   2.00
Latest Dividend Date 22 Sep 2016
Dividend Yield (%) 0.90
Book Value / Share () [*S] 1.46
P/B Ratio () [*S] 1.52
[*C] Consolidated     [*S] Standalone

Syncom Formulations (India) Ltd - Financial Results

Particulars ( cr) Sep 2016 Sep 2015 % Chg
Net Sales 47.19 50.12 -5.85
Other Income 0.87 0.42 107.14
Total Income 48.05 50.53 -4.91
Total Expenses 42.81 44.7 -4.23
Operating Profit 5.24 5.83 -10.12
Net Profit 2.97 3.2 -7.19
Equity Capital 78.07 78.07 -
> More on Syncom Formulations (India) Ltd Financials Results

Syncom Formulations (India) Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Coral Labs. 615.00 2.38 219.55
NGL Fine Chem 325.15 4.00 200.94
Albert David 343.70 -1.76 196.25
Syncom Formul. 2.22 0.45 173.32
DIL 754.35 -2.02 172.75
Bajaj Healthcare 235.40 -1.51 162.43
Ind-Swift Labs. 37.00 0.00 153.48
> More on Syncom Formulations (India) Ltd Peer Group

Syncom Formulations (India) Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 45.01
Banks/FIs 0.01
FIIs 0.00
Insurance 0.00
Mutual Funds 0.00
Indian Public 46.28
Custodians 0.00
Other 8.70
> More on Syncom Formulations (India) Ltd Share Holding Pattern

Syncom Formulations (India) Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week 0.00% NA 1.97% 2.16%
1 Month -3.48% NA -1.85% -2.02%
3 Month -14.29% NA -7.12% -6.82%
6 Month 7.77% NA -0.06% 0.71%
1 Year -48.49% NA 6.83% 8.53%
3 Year -51.10% NA 25.42% 29.82%

Syncom Formulations (India) Ltd - STOCK STRENGTH

Today's Low/High 2.17
2.30
Week Low/High 2.17
2.00
Month Low/High 1.91
2.00
YEAR Low/High 1.91
5.00
All TIME Low/High 0.14
15.00

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard